| 000 | 01112 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514163650.0 | ||
| 264 | 0 | _c20040423 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1567-5688 | ||
| 024 | 7 |
_a10.1016/s1567-5688(03)00033-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSydow, Karsten | |
| 245 | 0 | 0 |
_aADMA and oxidative stress. _h[electronic resource] |
| 260 |
_bAtherosclerosis. Supplements _cDec 2003 |
||
| 300 |
_a41-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xmetabolism |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xmetabolism |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xdrug effects |
| 650 | 0 | 4 |
_aOxidative Stress _xphysiology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aMünzel, Thomas | |
| 773 | 0 |
_tAtherosclerosis. Supplements _gvol. 4 _gno. 4 _gp. 41-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1567-5688(03)00033-3 _zAvailable from publisher's website |
| 999 |
_c14398285 _d14398285 |
||